Sapitinib
Properties
- Molecular formula
- C23H25ClFN5O3
- Molar mass
- 473.93 g/mol
- Exact mass
- 473.1630 Da
- logP
- 4.60Crippen estimate
- Polar surface area
- 92.1 Ų
- H-bond donors / acceptors
- 2 / 7
- Rotatable bonds
- 7
Hazards
Danger
- H302 Harmful if swallowed100% of notifiers
- H361 Suspected of damaging fertility or the unborn child100% of notifiers
- H372 Causes damage to organs through prolonged or repeated exposure100% of notifiers
Aggregated from 3 ECHA notifications, via PubChem; a share says how many notifiers assign that statement.
Precautionary statements
P203, P260, P264, P270, P280, P301+P317, P318, P319, P330, P405, P501
Identifiers
CAS number
848942-61-0SMILES
CN=C(O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1InChIKey
DFJSJLGUIXFDJP-UHFFFAOYSA-NInChI
InChI=1S/C23H25ClFN5O3/c1-26-21(31)12-30-8-6-14(7-9-30)33-20-10-15-18(11-19(20)32-2)27-13-28-23(15)29-17-5-3-4-16(24)22(17)25/h3-5,10-11,13-14H,6-9,12H2,1-2H3,(H,26,31)(H,27,28,29)Weigh it out
Type any one amount. The others follow from the molar mass.
Names and synonyms
6 names
- 1-Piperidineacetamide, 4-[[4-[(3-chloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-N-methyl-
- 4-[[4-[(3-Chloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-N-methyl-1-piperidineacetamide
- 4-(3-Chloro-2-fluoroanilino)-7-methoxy-6-[[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy]quinazoline
- AZD 8931
- Sapatinib
- 2-[4-[4-(3-Chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-methylacetamide
Work with Sapitinib
Similar compounds
Poziotinib1092364-38-957 % similar
Zorifertinib1626387-80-152 % similar
Zm 306416690206-97-443 % similar
Dacomitinib1110813-31-441 % similar
Gefitinib184475-35-241 % similar
(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide439081-18-240 % similar
Afatinib850140-72-640 % similar
4-(3-Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline hydrochloride184475-55-640 % similar
Tanimoto similarity of circular fingerprints over the whole catalogue.